SCPH Orbimed Advisors LLC buys $2.0M worth of shares
Aug 15, 2024, 9:34 PM
4.57%
What does SCPH do
scPharmaceuticals, Inc., based in Burlington, Massachusetts, focuses on developing subcutaneous pharmaceutical products like FUROSCIX for conditions such as congestive heart failure and infection treatments. The company, founded with 96 employees, went public in 2017 and prioritizes healthcare cost reduction and improved health outcomes.
Orbimed Advisors LLC bought 500,000 shares of SCPH on 13 August at $4.00 per share, worth a total of $2.0M. They now own 5,806,670 SCPH shares, or a 9% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
